OIA
MRNA icon

Optimum Investment Advisors’s Moderna MRNA Stock Holding History

Optimum Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-170
Closed -$7.07K – 646
2024
Q4 		$7.07K Sell
170
-734
-81% -$35.1K ﹤0.01% 534
2024
Q3 		$60.4K Sell
904
-480
-35% -$44.1K 0.03% 334
2024
Q2 		$164K Sell
1,384
-105
-7% -$13.3K 0.07% 207
2024
Q1 		$159K Buy
1,489
+200
+16% +$20.2K 0.07% 213
2023
Q4 		$128K Sell
1,289
-200
-13% -$16.8K 0.06% 227
2023
Q3 		$154K Hold
1,489
– – 0.08% 207
2023
Q2 		$181K Sell
1,489
-210
-12% -$28K 0.09% 197
2023
Q1 		$261K Sell
1,699
-325
-16% -$53.6K 0.14% 150
2022
Q4 		$364K Hold
2,024
– – 0.2% 121
2022
Q3 		$239K Sell
2,024
-200
-9% -$30.3K 0.13% 170
2022
Q2 		$318K Sell
2,224
-100
-4% -$14.3K 0.16% 135
2022
Q1 		$400K Sell
2,324
-100
-4% -$16.8K 0.17% 127
2021
Q4 		$616K Buy
2,424
+2,194
+954% +$641K 0.24% 93
2021
Q3 		$89K Sell
230
-170
-43% -$62.7K 0.04% 350
2021
Q2 		$94K Buy
400
+50
+14% +$8.94K 0.03% 392
2021
Q1 		$46K Buy
+350
New +$50.7K 0.01% 523
2020
Q2 		– Sell
-400
Closed -$12K – 901
2020
Q1 		$12K Buy
+400
New +$9.2K ﹤0.01% 656

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Optimum Investment Advisors's MRNA Position: Q1 2025 in Review

Optimum Investment Advisors sold out of Moderna (MRNA) in Q1 2025, closing a stake of 170 shares — an estimated $7.07K sold.

Optimum Investment Advisors first reported a position in MRNA in Q1 2020 and held it in 17 quarters. The position peaked at $616K in Q4 2021. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Optimum Investment Advisors reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Optimum Investment Advisors sold 170 Moderna shares in Q1 2025, an estimated $7.07K.
  • Optimum Investment Advisors first reported a position in Moderna in Q1 2020 and held it in 17 quarters.
  • Optimum Investment Advisors's Moderna position peaked at $616K in Q4 2021.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Optimum Investment Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.